ArticleFrontiers in pharmacology2019
Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Pooled it
- Factors predicting treatment response to biological and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis - a systematic review and meta-analysis.Clinical rheumatology · 2024Pooled it
- An Overview of Adalimumab Therapy for Ankylosing Spondylitis.Current rheumatology reviews · 2024Pooled it
- Prevalence, outcomes, and predictive factors: a systematic literature review to inform the development of EULAR Points to Consider for the definition of Difficult-to-Manage and Treatment-Refractory psoriatic arthritis.EULAR rheumatology open · 2026Article
- Co-occurrence of endometriosis with psoriasis and psoriatic arthritis: Genetic insights (Review).Experimental and therapeutic medicine · 2025Review
- Biological therapy for psoriatic arthritis: current state and future perspectives.Rheumatology international · 2024Review
- Oxidative Imbalance in Psoriasis with an Emphasis on Psoriatic Arthritis: Therapeutic Antioxidant Targets.Molecules (Basel, Switzerland) · 2024Review
- A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis.Scientific reports · 2024Article
- Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.Advances in therapy · 2023Article
- Acute joint swelling in psoriatic arthritis: Flare or "psout"-A 10-year-monocentric study on synovial fluid.Experimental biology and medicine (Maywood, N.J.) · 2022Article
- Sex- and gender-related differences in psoriatic arthritis.Nature reviews. Rheumatology · 2022Review
- Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis.Journal of personalized medicine · 2022Article
- Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement.Clinical rheumatology · 2022Article
- Article
- Corticosteroid injection treatment for dactylitis in psoriatic arthritis.Therapeutic advances in musculoskeletal disease · 2021Review
- Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future.Journal of experimental pharmacology · 2020Review
- Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden.Rheumatology advances in practice · 2020Article
- An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis.Biologics : targets & therapy · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors at 15 institutions in 1 country.
Salvatore D'AngeloRheumatology Department of Lucania, Rheumatology Institute of Lucania (IReL), Potenza, Italy.
Fabrizio CantiniDepartment of Rheumatology, Hospital of Prato, Prato, Italy.
Roberta RamondaRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Luca CantariniResearch Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Antonio CarlettoRheumatology Unit, University of Verona, Verona, Italy.
Maria Sole ChimentiRheumatology, Allergology and Clinical Immunology, Department of Medicina dei Sistemi, University of Rome Tor Vergata, Rome, Italy.
Andrea Delle SedieRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Rosario FotiRheumatology Unit, Vittorio-Emanuele University Hospital of Catania, Catania, Italy.
Roberto GerliRheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy.
Claudia LomaterRheumatology Unit, Ospedale Mauriziano, Torino, Italy.
Ennio LubranoAcademic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise, Campobasso, Italy.
Antonio MarchesoniDepartment of Rheumatology, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO, Milan, Italy.
Alen ZabottiRheumatology Clinic, Department of Medical Area, University of Udine, Academic Hospital S. Maria della Misericordia, Udine, Italy.
Carlo SalvaraniRheumatology Unit, Deptartment of Internal Medicine, Azienda USL-IRCCS, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.
Rossana ScrivoDipartimento di Medicina Interna e Specialità Mediche, Reumatologia, Sapienza Università di Roma, Rome, Italy.
Raffaele ScarpaRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Giuseppina TramontanoRheumatology Department of Lucania, Rheumatology Institute of Lucania (IReL), Potenza, Italy.
Carlotta NanniniDepartment of Rheumatology, Hospital of Prato, Prato, Italy.
Mariagrazia LorenzinRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Marta FabbroniResearch Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Federica MartinisRheumatology Unit, University of Verona, Verona, Italy.
Roberto PerriconeRheumatology, Allergology and Clinical Immunology, Department of Medicina dei Sistemi, University of Rome Tor Vergata, Rome, Italy.
Linda CarliRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Elisa VisalliRheumatology Unit, Vittorio-Emanuele University Hospital of Catania, Catania, Italy.
Guido RoveraRheumatology Unit, Ospedale Mauriziano, Torino, Italy.
Fabio Massimo PerrottaAcademic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute, Università degli studi del Molise, Campobasso, Italy.
Luca QuartuccioRheumatology Clinic, Department of Medical Area, University of Udine, Academic Hospital S. Maria della Misericordia, Udine, Italy.
Alessio AltobelliDipartimento di Medicina Interna e Specialità Mediche, Reumatologia, Sapienza Università di Roma, Rome, Italy.
Luisa CostaRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Laura NiccoliDepartment of Rheumatology, Hospital of Prato, Prato, Italy.
Augusta OrtolanRheumatology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Francesco CasoRheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Hospital of Prato · ITUniversity of Naples Federico II · ITUniversity of Padua · ITA. O. Ordine Mauriziano di Torino · ITAzienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele · ITSapienza University of Rome · ITUniversity of Molise · ITUniversity of Pisa · ITUniversity of Rome Tor Vergata · ITUniversity of Siena · ITUniversity of Udine · ITUniversity of Verona · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Ortopedico Gaetano Pini · ITUniversity of Perugia · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
adalimumabbiological drugspsoriatic arthritisreal-liferetention rate
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.